![]() |
市场调查报告书
商品编码
1930089
全球机械呼吸器市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Ventilator Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球机械呼吸器市场在现代医学中发挥着至关重要的作用,它为因严重呼吸系统疾病而无法自主呼吸的患者提供支持。 根据 Fortune Business Insights 预测,机械呼吸器市场规模预计在 2025 年达到 82.1 亿美元,并在 2026 年成长至 86.5 亿美元。长期来看,预计到 2034 年,该市场规模将达到 137.3 亿美元,2026 年至 2034 年的复合年增长率 (CAGR) 为 5.94%。
2025 年,北美在全球呼吸器市场占主导地位,市场占有率高达 59.38%,这得益于该地区较高的重症监护室 (ICU) 收治率、先进的医疗基础设施以及对重症监护技术的积极应用。
市场概览
机械呼吸器是一种生命维持设备,可为无法自主呼吸的患者提供机械通气。这些设备广泛应用于重症监护室 (ICU) 和急诊科,其在家庭医疗保健领域的应用也日益增加。 通气方法大致分为侵入性通气和非侵入性通气。由于有创通气已被临床证实有效,因此在重症和紧急情况下,有创通气是首选方案。
慢性呼吸系统疾病盛行率的上升、老年人口的增长以及全球重症监护室(ICU)入院人数的增加,是推动呼吸器需求的主要因素。根据美国重症医学会(SCCM)统计,美国每年有超过500万名患者入住ICU,其中约40-50%需要机械通气,凸显了这些设备的关键作用。
新冠疫情对呼吸器市场的影响
新冠疫情显着加速了全球对呼吸器的需求。重症患者数量的急剧增加暴露了多个国家医疗基础设施和呼吸机供应的短缺问题。 根据世界卫生组织(世卫组织)的数据,截至2020年5月18日,全球已报告约470万例新冠肺炎病例,其中许多患者需要入住加护病房并接受呼吸支援。
在美国,估计有96万名新冠肺炎患者可能需要呼吸机,而包括功能齐全和非功能齐全的型号在内的呼吸机可用供应量约为20万台。这种供需缺口迫使各国政府和製造商迅速扩大生产,进一步影响了市场的长期成长。
市场趋势
扩大产能
主要製造商透过迅速扩大生产来应对疫情。 例如,美敦力公司将产量提高了 40%,飞利浦的目标是将产能提高四倍,而 Getinge AB 的产量则从 2019 年的 1 万台增加到 2020 年的 26,000 台。这些努力加强了全球供应,并支持了市场的持续扩张。
技术进步
製造商正专注于先进的 ICU 呼吸器、便携式系统、改进的连接性和增强的监测功能。数位平台和基于云端的监测系统的整合正在改善患者管理和临床结果,尤其是在重症监护环境中。
市场驱动因素
加护病房 (ICU) 入院人数增加
由于呼吸系统疾病、吸烟和肥胖等生活方式因素以及传染病导致的 ICU 入院人数增加是关键的成长驱动因素。 德国约有 42% 的 ICU 患者需要使用呼吸机,美国约有 45% 的 ICU 患者需要呼吸支持,这凸显了已开发市场对呼吸机的强劲需求。
产品创新
领先企业持续推出技术先进的呼吸器。值得关注的产品包括德尔格 (Dräger) 的 Evita V600 和 V800 ICU 呼吸机、汉密尔顿医疗 (Hamilton Medical) 的 HAMILTON-C6 以及日本光电 (Nihon Kohden) 的 NKV-550 系列,这些产品有助于提高临床效率并促进呼吸器的广泛应用。
市场限制因子
儘管需求强劲,呼吸器相关併发症(例如呼吸器相关性肺炎 (VAP))仍然是一个挑战。研究表明,约 80% 的医院获得性肺炎病例与呼吸器相关,这可能会限制呼吸器的使用并影响临床决策。
依类型
此市场细分为成人呼吸器和儿科/新生儿呼吸器。到2026年,成人呼吸器市占率将达到61.01%,主要驱动因素是老年患者入住加护病房(ICU)人数的增加。
依介面
根据接口,市场分为有创呼吸器和非侵入性呼吸器。由于有创呼吸器在ICU环境中应用广泛,到2026年,其市占率将达到88.84%,占主导地位。
依最终使用者
医院是最大的最终使用者群体,到2026年将占56.29%的市场占有率,主要驱动因素是ICU入院人数的增加和医院基础设施的扩建。
预计到2025年,北美呼吸器市场规模将达到48.7亿美元,其中美国市场预计到2026年将达到47.4亿美元。欧洲占第二大市场占有率,预计2026年,德国市场规模将达5.3亿美元,英国将达1亿美元。
在亚太地区,重症监护室(ICU)入院人数的增加和本地产能的扩大正在推动市场成长。预计到2026年,中国市场规模将达到5.1亿美元,日本将达到3.2亿美元,印度将达到2.9亿美元。
The global ventilators market plays a critical role in modern healthcare by supporting patients who are unable to breathe independently due to severe respiratory conditions. According to Fortune Business Insights, the ventilators market size was valued at USD 8.21 billion in 2025 and is projected to grow to USD 8.65 billion in 2026. Over the long term, the market is forecasted to reach USD 13.73 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 5.94% during the 2026-2034 forecast period.
North America dominated the global ventilators market in 2025 with a 59.38% market share, supported by high ICU admission rates, advanced healthcare infrastructure, and strong adoption of critical care technologies.
Market Overview
Ventilators are life-support devices that provide mechanical ventilation to patients who cannot breathe adequately on their own. These devices are widely used in intensive care units (ICUs), emergency departments, and increasingly in homecare settings. Ventilation can be broadly categorized into invasive and non-invasive modes, with invasive ventilation being preferred in severe and emergency conditions due to its clinically proven effectiveness.
The rising prevalence of chronic respiratory diseases, growing geriatric population, and increasing number of ICU admissions worldwide are major factors driving demand for ventilators. According to the Society of Critical Care Medicine, more than 5 million patients are admitted to ICUs annually in the U.S., with approximately 40-50% requiring mechanical ventilation, highlighting the essential role of these devices.
Impact of COVID-19 on the Ventilators Market
The COVID-19 pandemic significantly accelerated demand for ventilators globally. The sudden surge in critically ill patients exposed gaps in healthcare infrastructure and ventilator availability across multiple countries. According to the World Health Organization, around 4.7 million COVID-19 cases were reported globally as of May 18, 2020, many of which required ICU admission and respiratory support.
In the U.S., estimates suggested that nearly 960,000 COVID-19 patients could require mechanical ventilation, compared to an available supply of approximately 200,000 ventilators, including full-featured and non-full-featured devices. This supply-demand gap prompted governments and manufacturers to rapidly scale production, further influencing long-term market growth.
Market Trends
Scaling Up Production Capacity
Key manufacturers responded to the pandemic by rapidly increasing production. For instance, Medtronic increased production by 40%, Philips targeted a fourfold capacity increase, and Getinge AB expanded output from 10,000 units in 2019 to 26,000 units in 2020. These initiatives strengthened global supply and supported sustained market expansion.
Technological Advancements
Manufacturers are focusing on advanced ICU ventilators, portable systems, improved connectivity, and enhanced monitoring features. The integration of digital platforms and cloud-based monitoring systems is improving patient management and clinical outcomes, particularly in critical care environments.
Market Drivers
Rising ICU Admissions
The increasing number of ICU admissions due to respiratory diseases, lifestyle factors such as smoking and obesity, and infectious diseases is a major growth driver. In Germany, approximately 42% of ICU patients require mechanical ventilation, while in the U.S., around 45% of ICU admissions need ventilatory support, underscoring strong demand across developed markets.
Product Innovation
Key players continue to launch technologically advanced ventilators. Notable introductions include Drager's Evita V600 and V800 ICU ventilators, Hamilton Medical's HAMILTON-C6, and Nihon Kohden's NKV-550 series, supporting clinical efficiency and expanding adoption.
Market Restraints
Despite strong demand, the market faces challenges from ventilator-associated complications such as ventilator-associated pneumonia (VAP). Studies indicate that around 80% of nosocomial pneumonias are linked to mechanical ventilation, which may limit usage in certain cases and impact clinical decision-making.
By Type
The market is segmented into adult and pediatric & neonatal ventilators. The adult segment dominated with a 61.01% market share in 2026, driven by higher ICU admissions among the elderly population.
By Interface
Based on interface, the market includes invasive and non-invasive ventilators. The invasive segment held a dominant 88.84% share in 2026, due to higher adoption in ICU settings.
By End User
Hospitals represent the largest end-user segment, accounting for 56.29% market share in 2026, supported by rising ICU admissions and expanding hospital infrastructure.
The North America ventilators market was valued at USD 4.87 billion in 2025, with the U.S. market projected to reach USD 4.74 billion by 2026. Europe holds the second-largest share, with Germany projected at USD 0.53 billion and the U.K. at USD 0.10 billion by 2026.
In Asia Pacific, growth is driven by increasing ICU admissions and local manufacturing. By 2026, China is projected to reach USD 0.51 billion, Japan USD 0.32 billion, and India USD 0.29 billion.
Conclusion
The global ventilators market, valued at USD 8.21 billion in 2025, is projected to grow to USD 8.65 billion in 2026 and reach USD 13.73 billion by 2034. Continuous growth in ICU admissions, technological advancements, and rising demand for critical care equipment are expected to support market expansion during the forecast period.
Segmentation By Type
By Interface
By End-User
By Geography